Preventive Medicine Institute

UEI
MKMCB9BPZKX8
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Phase II clinical trial of celecoxib (or nsaid) for prevention of sporadic colorectal adenomas HHS261995015 National Cancer Institute (NIH) $0
Definitive Contract 00261200212D261035106 National Cancer Institute (NIH) $499,000
Definitive Contract 00261200212D261035107 National Cancer Institute (NIH) $494,668
Preclinical evaluation of intermediate endpoints and their modulation by chemopreventive agents, WS 64 00261200209D261025122 National Cancer Institute (NIH) $494,126
Definitive Contract 00261200209D261025018 National Cancer Institute (NIH) $488,000

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Preventive Medicine Institute registered in SAM.gov?

Preventive Medicine Institute's SAM.gov registration expired on September 29, 2005.

What is Preventive Medicine Institute's most recent federal award?

Preventive Medicine Institute's most recent federal contract award is Phase II clinical trial of celecoxib (or nsaid) for prevention of sporadic colorectal adenomas (HHS261995015), from National Cancer Institute (NIH), on September 29, 2005.

On GovTribe

See Preventive Medicine Institute's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login